Fifty 1 Labs, Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Joel Gagnier
- Full Time Employees
- 25
- Sector
- Financial Services
- Industry
- Financial - Credit Services
- Address
- 8430 West Lake Mead Boulevard Las Vegas NV United States of America 89128
- IPO Date
- Jul 18, 2005
- CIK
- 0001716913
- Website
- fifty1labs.com
- Similar Companies
- Business
- Fifty 1 Labs, Inc. (FITY) operates as a Nevada-based holding company focused on health, wellness, and biotechnology through AI-driven drug repurposing and functional medicine. Founded in 1998 and headquartered at 8430 West Lake Mead Boulevard, Las Vegas, Nevada, the company conducts operations primarily in the United States with expansion plans including R&D hubs in Florida. It wholly owns subsidiaries such as Fifty1 AI Labs LLC, which develops AI technologies to repurpose off-patent compounds for therapies in wellness and functional medicine; 51 LLC, offering sports nutrition supplements including pre-workout formulas, BCAAs, ION+ Electrolyte Formula, Turmeric Gummies, and Ashwagandha Gummies to enhance athletic performance and recovery; and Genetic Networks following its acquisition. The company targets athletes, fitness enthusiasts, wellness seekers, biotech investors, and government sectors such as the Department of Defense for applications like astronaut health via partnerships. In recent developments, Fifty 1 Labs completed a $10 million acquisition of Genetic Networks in March 2025, appointing Dr. Gennaro D'Urso as CEO and Chairman to advance GeneScape for drug repurposing and rare diseases; signed a letter of intent in September 2025 to acquire BioSpark AI Technologies for enhanced AI large language models in medical literature analysis; entered a strategic partnership with LUNR Aerospace for AI-driven solutions; and executed a name and symbol change while pursuing OTC compliance in March 2025.
Fifty 1 Labs, Inc. Accelerates Peptide Biotechnology Push into Musculoskeletal Health
Fifty 1 Labs, Inc. Eliminates 612 Million Shares from the Market
Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Collaboration with LUNR Aerospace
Fifty 1 Labs Inc. Appoints Dr. Joel Gagnier as Chief Science Officer
Fifty 1 Labs Inc. Signs Letter of Intent to Acquire BioSpark AI Technologies Inc.
Fifty 1 Labs, Inc. Engages PCAOB Auditing Firm to Prepare for Uplist to OTCQB
Fifty1 Labs, Inc. Leadership Publishes Landmark Framework to Unlock Global Oncology Data Through AI-Driven Real-World Evidence
Fifty1 Labs Partners with LUNR Aerospace to Pioneer AI-Driven Drug Repurposing for Space Medicine, Strategic Collaboration Aims to Harness AI and Orbital Access to Revolutionize Astronaut Health Solutions in a $2 Billion Market by 2032
Fifty 1 Labs, Inc. and The Gates Foundation Lead Largest-Ever Sickle Cell Disease Study, Unlocking Pathways for Gene-Based and Repurposed Therapies
Fifty1 Labs, Inc. and BioSpark AI Unlock 2,000+ Real-World Treatment Pathways to Accelerate Functional Medicine Innovation
Fifty 1 Labs, Inc. (FITY) Sparks AI Breakthrough in Drug Repurposing: Subsidiary Fifty1 AI Labs Announces Strategic Partnership with Intent to Acquire BioSpark AI Technologies
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership
Fifty 1 Labs, Inc. Accelerates Growth with New CEO, BioSentry Division Launch and Shareholder Dividend; Company Pursues Strategic Growth Through UAV Partnership and Targeted Acquisitions in Advanced Tech and Wellness
UAV Corp. Drives Growth with Partnership, Dividend, New Leadership, and DART SA-70 Test Success
UAV Corp Names David Dugas as President and Chief Operating Officer
UAV Corp and Genetic Networks Announce Strategic Collaboration to Combat Biohazards with Cutting-Edge Technology, Genetic Networks Signs MOU with UMAV
UAV Corp and Genetic Networks Announce Strategic Collaboration to Combat Biohazards with Cutting-Edge Technology
Fifty 1 Labs, Inc. Celebrates Groundbreaking SpaceX, NASA, and ISS Yeast Experiment by Subsidiary Genetic Networks
4Cable TV International, Inc. (CATV) Facilitates Acquisition of Genetic Networks LLC by Fifty 1 Labs, Inc. (FITY), Announces Dividend for CATV Shareholders, and Sets Stage for Transformative Reverse Merger
Fifty 1 Labs, Inc. Completes Name and Symbol Change, Advances Toward Regaining 15c211 Compliance